Dubourg C et al. Holoprosencephaly. Orphanet J Rare Dis. 2007;2:8. PMID: 17274816.
Dubourg C et al. Mutational Spectrum in Holoprosencephaly Shows That FGF is a New Major Signaling Pathway. Hum Mutat. 2016;37(12):1329–1339. PMID: 27363716.
Mercier S et al. New findings for phenotype-genotype correlations in a large European series of holoprosencephaly cases. J Medical Genet. 2011;48(11):752–760. PMID: 21940735.
Roessler E et al. Loss-of-function mutations in the human GLI2 gene are associated with pituitary anomalies and holoprosencephaly-like features. Proc Natl Acad Sci U S A. 2003;100(23):13424-9. PMID: 14581620.
Bear KA et al. Pathogenic mutations in GLI2 cause a specific phenotype that is distinct from holoprosencephaly. J Med Genet. 2014;51(6):413‑8. PMID: 24744436.
Arnhold IJP et al. Role of GLI2 in hypopituitarism phenotype. J Mol Endocrinol. 2015;54(3):R141‑50. PMID: 25878059.
Kim A et al. Integrated clinical and omics approach to rare diseases: novel genes and oligogenic inheritance in holoprosencephaly. Brain J Neurol. 2019;142(1):35‑49. PMID: 30508070.